Severe congestive heart failure as medical emergency;Die schwere Herzinsuffizienz als medizinischer Notfall

Praxis

Volumn 86, Issue 6, 1997, Pages 189-195

  Hunziker, P ^a   Pfisterer, M ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

diagnosis; emergency; heart failure; prognosis; therapy

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; GLYCERYL TRINITRATE; INOTROPIC AGENT; NITROPRUSSIDE SODIUM; SPIRONOLACTONE;

CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; EMERGENCY TREATMENT; HUMAN; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW;

ACUTE DISEASE; ALGORITHMS; COMBINED MODALITY THERAPY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; NEUROTRANSMITTER AGENTS; PHYSICAL EXAMINATION; PROGNOSIS; PULMONARY EDEMA;

EID: 0031046989     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Wagdi Ph., Vuilliomenet A., Kaufmann U., et al.: Schweiz. med. Wschr. 123, 108-112 (1993).
2. The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart feilure. Eur Heart J 16, 741-751 (1995).
3. World Health Organisation Task Force on Heart Failure Education. Concise Guide to the Management of Heart Failure.
4. The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 16, 741-51 (1995).
5. Brutsaert D. L., Sys S. U., Gillebert T. C: Diastolic failure - pathophysiology and therapeutic implications. J Am Coll Cardiol 22, 318-325 (1993).
6. Swedberg K., Eneroth R, Kjekshus J., Wilhelmsen L. for the CONSENSUS Trial Study Group. Hormones regulation cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Circulation 82, 1730-1760 (1990).
7. Wei C. M., Kao P. C., Lin J. T. et al: Circulating beta atrial natriuretic factor in congestive heart failure in humans. Circulation 88, 1016-1020 (1993).
8. Kundel H. L., Revesz G.: Digital analysis of chest radiographs in pulmonary vascular congestion. Radiology 143, 407-410 (1982).
9. Kostuk W., Barr J. W., Sion A. L, Ross J. R.: Correlations between the chest film and hemodynamics in acute myocardial infarction. Circulation 48, 624-32 (1973).
10. Chakko S., Woska D., Martinez H., De Marchena E., Futterman L., Kessler K. M. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med 90, 353-9 (1991).
11. Remes J., Miettinen H., Reunanen A., et al.: Validity of clincial diagnosis of heart failure in primary health care. Eur Heart J 12, 315-321 (1991).
12. The Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 16, 741-51 (1995).
13. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study. N Engl J Med 316, 1429-1435 (1987).
14. Cohn J. N., Archibald D. G., Ziesche S. et al: A Effects of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study (V-HeFT I). N Engl J Med 314, 1547-1552 (1986).
15. Cohn J. N., Johnson G., Ziesche S. et al.: A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure (V-HeFt II). N Engl J Med 325, 303-310 (1991).
16. Stevenson L. W., Tillisch J. H.: Maintenance of cardiac output with normal filling pressures in patients with dilated heart failure. Circulation 74, 1303-1308 (1986).
17. Bayliss J., Norell M., Canepa-Anson R. et al.: Untreated heart failure: clinical and neruoendocrine effects of introducing diuretics. Br Heart J 57, 17-22 (1987).
18. Pcker M., Cerver J., Rodeheffer R., Ivanhoe R., DiBianco R., Zeldis S. for the promise Study Research Group: Effect of oral milrinone on mortality in severe chronic heart failure. New Engl. J. Med. 329, 149-155 (1991).
19. CowleyA. J., Skene A. M.: Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators. Br Heart J 1994: 72, 226-230.
20. Doval C. D., Nul D. R., Grancelli H. O. et al.: for the Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Amiodarone in congestive heart failure. Lancet 344, 493-498 (1994).
21. Echt D. S., Liebson P. R., Mitchell L. B. et al.: Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial (CAST). N Engl J Med 324: 493-8 (1991).
22. Singh S. N., Ross D., Fletscher S. G. et al.: Results of the Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy. Circulation 90, 1-546 (1994).
23. Meltzer R. S., Visser C. A., Faster V.: Intracardiac thrombi and systemic embolisation. Ann Intern Med 104, 689-698 (1986).
24. Fuster V., Gersh B. J., Guliani E. R. et al.: The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 47, 523-531 (1981).
25. Packer M.: Praise: safety and survival of heart failure treated with amlodipine. European Congress of Cardiology 1995 Aug. Oral presentation.
26. Packer M.: Pathophysiologic mechanisms underlying the adverse effects of calcium channel blocking drugs in patients with chronic heart failure. Circulation 80 (Suppl. IV), 59-67 (1989).
27. Goldstein R., Bocuzzi S., Cruess D., Nattel S.: The Adverse Experience Committee and the Multicenter Diltiazem Post-Infarction Research Group. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 83, 52-60 (1991).
28. Keteyian S. J., Levine A. B., Browner C. A., Kataoka T., Rogers F. J., Schairer J. R., Stein P. D., Levine T. B., Goldstein S.: Exercise training in patients with heart failure: a randomized, controlled trial. Ann Intern Med 1996; 124: 1051-7.
29. CIBIS Investigators and Committees. A randomized trial of beta blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994: 90, 1765-1773.
30. Waagstein F., Bristow M. R., Swedberg K. et al.: Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet 1993: 342, 1441-1446.
31. Packer M., Bristow M. R., Cohn J. N. et al.: The effect of carvedilol on morbidity and mortality in patients wiht chronic heart failure. N Engl J Med 1996; 334: 1349-1355.
32. Barr C. S., Lang C. C, Hanson J., Arnott M., Kennedy N., Struther A. D.: Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1995, 76, 1259-65.
33. Kiowski W., Sütsch G., Hunziker P. et al.: Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 346, 732-736 (1995).
34. Hagemeijer E: Calcium sensitization with pimobendan: pharmacology, hemodynamic improvement, and sudden death in patients with chronic congestive heart failure. Eur Heart J 1993: 14, 551-566.
35. Boiling S. F., Deeb G. M., Brunsting L. A., Bach D. S.: Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J Thorac Cardiovasc Surg 1995: 109, 676-82.
36. Carpentier A., Chachques J. C.. Acar C. et al.: Dynamic cardiomyoplasty at seven years. J Thorac Cardiovasc Surg 1993: 106, 42-52.